AMY RUSSELL: Open Payments
NPI 1376788588 · CAMILLUS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,522 in 76 payments from 21 companies in 2025. Trend: 2023 $1,151 · 2024 $1,795 · 2025 $1,522
Food & beverage: $1,522
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $414 |
| ABBVIE INC. | 16 | $180 |
| PFIZER INC. | 13 | $162 |
| Corcept Therapeutics | 4 | $116 |
| Amgen Inc. | 7 | $110 |
| Novo Nordisk Inc | 3 | $61 |
| GlaxoSmithKline, LLC. | 2 | $53 |
| Exact Sciences Corporation | 2 | $52 |
| Merck Sharp & Dohme LLC | 3 | $46 |
| Corium, LLC | 3 | $46 |
Products named: BREZTRI, FARXIGA, Korlym, AIRSUPRA, UBRELVY, NURTEC ODT, VRAYLAR, REPATHA.
Industry payments across NY — which companies pay providers there.
